HNB
RARE icon

Huntington National Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Huntington National Bank’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6K Buy
1,081
+16
+2% +$360 ﹤0.01% 1608
2025
Q4 		$24.5K Sell
1,065
-27
-2% -$888 ﹤0.01% 1511
2025
Q3 		$32.8K Buy
1,092
+393
+56% +$11.8K ﹤0.01% 1429
2025
Q2 		$25.4K Buy
699
+209
+43% +$7.54K ﹤0.01% 1489
2025
Q1 		$17.7K Sell
490
-65
-12% -$2.7K ﹤0.01% 1567
2024
Q4 		$23.3K Buy
555
+7
+1% +$347 ﹤0.01% 1497
2024
Q3 		$30.4K Buy
548
+71
+15% +$3.62K ﹤0.01% 1377
2024
Q2 		$19.6K Buy
477
+46
+11% +$1.96K ﹤0.01% 1462
2024
Q1 		$20.1K Sell
431
-11
-2% -$519 ﹤0.01% 1457
2023
Q4 		$21.1K Sell
442
-75
-15% -$2.91K ﹤0.01% 1402
2023
Q3 		$18.4K Buy
517
+153
+42% +$6.06K ﹤0.01% 1375
2023
Q2 		$16.8K Buy
+364
New +$16.9K ﹤0.01% 1418
2019
Q1 		– Sell
-60
Closed -$3K – 1748
2018
Q4 		$3K Buy
+60
New +$3.28K ﹤0.01% 1529
2016
Q4 		– Sell
-9
Closed – – 1493
2016
Q3 		$0 Hold
9
– – ﹤0.01% 1565
2016
Q2 		$0 Sell
9
-302
-97% -$19.5K ﹤0.01% 1633
2016
Q1 		$19K Buy
311
+111
+56% +$7.26K ﹤0.01% 1370
2015
Q4 		$22K Sell
200
-34
-15% -$3.4K ﹤0.01% 1203
2015
Q3 		$23K Sell
234
-142
-38% -$16.3K ﹤0.01% 1227
2015
Q2 		$38K Buy
376
+65
+21% +$5.05K ﹤0.01% 1184
2015
Q1 		$19K Buy
+311
New +$17.3K ﹤0.01% 1374

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Huntington National Bank's RARE Position: Q1 2026 in Review

Huntington National Bank increased its Ultragenyx Pharmaceutical (RARE) stake by 1.5% in Q1 2026, buying an estimated $360 and bringing the position to 1,081 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1608.

Huntington National Bank first reported a position in RARE in Q1 2015 and has held it in 20 quarters since. The position peaked at $38K in Q2 2015. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • Huntington National Bank held 1,081 shares of Ultragenyx Pharmaceutical worth $22.6K as of Q1 2026.
  • Huntington National Bank bought 16 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $360.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #1608 holding.
  • Huntington National Bank first reported a position in Ultragenyx Pharmaceutical in Q1 2015 and has held it in 20 quarters since.
  • Huntington National Bank's Ultragenyx Pharmaceutical position peaked at $38K in Q2 2015.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.